IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
Authors
Keywords
IL-6, p-STAT3, Chronic hepatitis, Hepatocellular carcinoma
Journal
BMC GASTROENTEROLOGY
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-24
DOI
10.1186/s12876-015-0283-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetics of breast cancer bone metastasis: a sequential multistep pattern
- (2014) Hassan Fazilaty et al. CLINICAL & EXPERIMENTAL METASTASIS
- STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression
- (2014) Hasaya Dokduang et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice
- (2014) Laxmidhar Das et al. LEUKEMIA & LYMPHOMA
- Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma
- (2013) Yingtai Chen et al. LEUKEMIA RESEARCH
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- STAT proteins – Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver
- (2012) Bin Gao et al. JOURNAL OF HEPATOLOGY
- Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients
- (2012) Jung-Ta Kao et al. LIVER INTERNATIONAL
- Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates
- (2011) Kui Li et al. HEPATOLOGY
- JAK/STAT/SOCS-signaling pathway and colon and rectal cancer
- (2011) Martha L. Slattery et al. MOLECULAR CARCINOGENESIS
- New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers
- (2010) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
- (2009) A. SINGAL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Interleukin-27 displays interferon-γ-like functions in human hepatoma cells and hepatocytes
- (2009) Herdis Bender et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now